Dana-Farber Cancer Institute Senior Product Manager Salaries in Baltimore, MD
The average Dana-Farber Cancer Institute Senior Product Manager in Baltimore, MD earns an estimated $129,238 annually, which includes an estimated base salary of $111,738 with a $17,500 bonus. Dana-Farber Cancer Institute's Senior Product Manager compensation is $24,810 less than the US average for a Senior Product Manager. Senior Product Manager salaries at Dana-Farber Cancer Institute in Baltimore, MD can range from $102,000 - $140,000.
In Baltimore, MD, The Product Department at Dana-Farber Cancer Institute earns $11,409 more on average than the HR Department.
Last updated a year ago.
- $111,738
- avg. base
- $17,500
- avg. bonus
Senior Product Manager Salaries at Dana-Farber Cancer Institute
In Baltimore, MD, Senior Product Managers earn $8,759 more than Senior Product Managers, and $48,144 less than Directors of Product.
Compensation at Dana-Farber Cancer Institute by Department
In Baltimore, MD, The Product Department averages $11,409 more than the HR Department, and $32,781 less than the Enterprise Risk Department
Senior Product Manager Compensation by Gender (All Companies)
The average female Senior Product Manager at companies similar size to Dana-Farber Cancer Institute reported making $153,279, while the average male Senior Product Manager at similar sized companies reported making $159,665.
Senior Product Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Senior Product Manager at companies similar size to Dana-Farber Cancer Institute reported making $163,000, while the average Native American Senior Product Manager at similar sized companies reported making $135,000.
How Senior Product Managers at Dana-Farber Cancer Institute Rate Their Compensation
The majority of Senior Product Managers at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Senior Product Managers at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute
